This app provides adult patients treated with KEYTRUDA® (pembrolizumab) easy access to information about their treatment. You must be a current patient on treatment with KEYTRUDA in Australia and be 18 years and older in order to access this app. If you cannot locate your access code, please contact your healthcare professional. For MSD medical information, please contact: 1800 818 553. Merck Sharp & Dohme (Australia) Pty Limited, Level 1, Building A, 26 Talavera Road, Macquarie Park NSW 2113, Australia. ONCO-1257980-0020 First issued Dec 2018 less
|